AGM/EGMApr 26, 2026, 05:29 AM
EVH 2026 AGM: Director Election, Incentive Plan; 2025 Rev $1.88B, Adj EBITDA $151.2M
AI Summary
Evolent Health, Inc. (EVH) announced its 2026 Annual Meeting of Stockholders for June 4, 2026, where shareholders will vote on the election of ten director nominees, ratification of Deloitte & Touche LLP as auditors, advisory approval of 2025 executive compensation, and an amendment to the 2015 Omnibus Incentive Compensation Plan. The company reported 2025 revenue of $1,876.2 million and Adjusted EBITDA of $151.2 million, alongside a net loss of $(579.4) million. Strategic achievements in 2025 included record new business wins, refinancing 2025 convertible notes, and the sale of Evolent Care Partners to reduce debt.
Key Highlights
- 2026 Annual Meeting of Stockholders set for June 4, 2026.
- Shareholders to vote on election of ten director nominees.
- Proposal to amend 2015 Incentive Plan to increase share availability.
- 2025 Revenue reported at $1,876.2 million.
- 2025 Adjusted EBITDA reached $151.2 million.
- 2025 Net loss attributable to common shareholders was $(579.4) million.
- Refinanced 2025 convertible notes, extending maturity to Dec 2029.
- Sold Evolent Care Partners to reduce senior debt and interest.